Send the following on WhatsApp
Continue to ChatMieloma multiplo, approvato anche in Italia il coniugato anticorpo-farmaco belantamab mafodotin https://www.tuttosanita.com/mieloma-multiplo-approvato-anche-in-italia-il-coniugato-anticorpo-farmaco-belantamab-mafodotin/